Sign in

CIK 0001816736

  • Large accelerated filer

Disc Medicine, Inc.

Sign in to watch
Ticker
IRON
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
851612845
Phone
+1 617-674-9274
Business address
321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
Former names
Gemini Therapeutics, Inc. /DE, FS Development Corp.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$11,877,065
in 6 filings, $10.0M under 10b5-1 plans

Net −$11,877,065. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 32 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-05-01 White William Richard Director Sale 10b5-1 −162 $28.52 $5K 39
2024-05-01 White William Richard Director Sale 10b5-1 −39 $29.11 $1K 0
2024-05-01 White William Richard Director Option exercise · Stock Option (Right to Buy) 10b5-1 −201 3,211
2024-04-11 White William Richard Director Option exercise 10b5-1 +1,756 $2.65 $5K 1,756
2024-04-11 White William Richard Director Option exercise 10b5-1 +804 $9.86 $8K 2,560
2024-04-11 White William Richard Director Sale 10b5-1 −2,482 $31.79 $79K 78
2024-04-11 White William Richard Director Sale 10b5-1 −78 $32.18 $3K 0
2024-04-11 White William Richard Director Option exercise · Stock Option (Right to Buy) 10b5-1 −1,756 5,268
2024-04-11 White William Richard Director Option exercise · Stock Option (Right to Buy) 10b5-1 −804 3,412
2024-04-10 Savage William Jacob Chief Medical Officer Option exercise +21,870 $2.65 $58K 43,405
2024-04-10 Savage William Jacob Chief Medical Officer Option exercise · Stock Option (Right to Buy) −13,093 4,233
2024-04-10 Savage William Jacob Chief Medical Officer Option exercise · Stock Option (Right to Buy) −8,777 1,498
2024-03-05 Bitterman Kevin Director Sale −26,157 $73.50 $1.9M 677,503
2024-02-26 Stephenson Pamela Chief Commercial Officer Grant or award +36,666 36,666
2024-02-26 Stephenson Pamela Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +55,000 55,000
2024-02-07 Franchi Jean M. Chief Financial Officer Grant or award +36,666 36,666
2024-02-07 Franchi Jean M. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +55,000 55,000
2024-01-23 Bitterman Kevin Director Sale −82,500 $67.65 $5.6M 703,660
2024-01-23 Bitterman Kevin Director Sale −20,000 $67.65 $1.4M 198,326
2024-01-23 Atlas Venture Fund X, L.P. 10% owner Sale −47,500 $67.65 $3.2M 1,402,186

Page 22 of 32 · 639 trades